TARA Mind

The company's core business revolves around a collaborative care platform that connects individuals with a vetted national network of therapists and clinics specialized in therapies like Ketamine-Assisted Therapy (KAT). TARA Mind's business model is centered on partnering with self-funded employers to offer its services as a supplemental health benefit. This approach is designed to make treatments, which are often paid for out-of-pocket, more affordable for employees while providing employers a return on investment through reduced medical costs, lower absenteeism, and increased productivity. The platform provides proprietary digital tools for measurement-based care, supporting a structured protocol of Preparation, Treatment, Integration, and Monitoring (PTIM™) to ensure safety and effectiveness. For providers, the platform offers fully-funded referrals, simplified billing, and free access to training and collaborative tools.

Since its inception, TARA Mind has secured $22 million in seed funding over three rounds, with its latest round in January 2024 raising $8 million. Key investors include Red Cell Partners, Satori Capital, Empath Ventures, and Echo Investment Capital. The company, headquartered in McLean, Virginia, is structured to align the interests of patients, providers, and employers to tackle accessibility and affordability issues within the mental healthcare system.